Fig. 2From: Genome editing via non-viral delivery platforms: current progress in personalized cancer therapySchematic illustration of electroporation- and CPP-mediated delivery of GETs. a The activated human T cells reprogrammed by electroporation-mediated genome editing reduce the tumor burden of melanoma-bearing mice. b CPPs facilitate the genome editing in cancer cells which could be used to establish xenograft modelsBack to article page